Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ryosuke Shirasaki, Ph.D., M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Matsumoto K, Matsuyama T, Sumiyoshi R, Takuji M, Yamamoto T, Shirasaki R, Tashiro H. Type 1 diabetes mellitus after cord blood transplantation from an unrelated donor with a disease-sensitive haplotype. J Diabetes Investig. 2023 Feb; 14(2):344-347. PMID: 36321643; PMCID: PMC9889600.
    Citations:    Fields:    Translation:Humans
  2. Matsuo T, Tashiro H, Shirasaki R, Sumiyoshi R, Yamamoto T, Saito S, Matsumoto K, Ooi J, Shirafuji N. Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients. Medicine (Baltimore). 2022 Jul 29; 101(30):e29541. PMID: 35905283; PMCID: PMC9333492.
    Citations:    Fields:    
  3. Sumiyoshi R, Tashiro H, Shirasaki R, Matsuo T, Yamamoto T, Matsumoto K, Ooi J, Shirafuji N. The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients. Leuk Res. 2022 02; 113:106790. PMID: 35092883.
    Citations:    Fields:    Translation:HumansCells
  4. Gupta VA, Barwick BG, Matulis SM, Shirasaki R, Jaye DL, Keats JJ, Oberlton B, Joseph NS, Hofmeister CC, Heffner LT, Dhodapkar MV, Nooka AK, Lonial S, Mitsiades CS, Kaufman JL, Boise LH. Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood. 2021 07 01; 137(26):3604-3615. PMID: 33649772; PMCID: PMC8462405.
    Citations: 13     Fields:    Translation:HumansCells
  5. Dhimolea E, de Matos Simoes R, Kansara D, Al'Khafaji A, Bouyssou J, Weng X, Sharma S, Raja J, Awate P, Shirasaki R, Tang H, Glassner BJ, Liu Z, Gao D, Bryan J, Bender S, Roth J, Scheffer M, Jeselsohn R, Gray NS, Georgakoudi I, Vazquez F, Tsherniak A, Chen Y, Welm A, Duy C, Melnick A, Bartholdy B, Brown M, Culhane AC, Mitsiades CS. An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence. Cancer Cell. 2021 02 08; 39(2):240-256.e11. PMID: 33417832; PMCID: PMC8670073.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  6. Shirasaki R, Matthews GM, Gandolfi S, de Matos Simoes R, Buckley DL, Raja Vora J, Sievers QL, Brüggenthies JB, Dashevsky O, Poarch H, Tang H, Bariteau MA, Sheffer M, Hu Y, Downey-Kopyscinski SL, Hengeveld PJ, Glassner BJ, Dhimolea E, Ott CJ, Zhang T, Kwiatkowski NP, Laubach JP, Schlossman RL, Richardson PG, Culhane AC, Groen RWJ, Fischer ES, Vazquez F, Tsherniak A, Hahn WC, Levy J, Auclair D, Licht JD, Keats JJ, Boise LH, Ebert BL, Bradner JE, Gray NS, Mitsiades CS. Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins. Cell Rep. 2021 01 05; 34(1):108532. PMID: 33406420.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  7. Matsuo T, Tashiro H, Sumiyoshi R, Saito S, Shirasaki R, Shirafuji N. Functional expression cloning of molecules inducing CD34 expression in bone marrow-derived stromal myofibroblasts. Biochem Biophys Res Commun. 2020 12 17; 533(4):1283-1289. PMID: 33066959.
    Citations:    Fields:    Translation:HumansCells
  8. Tashiro H, Shirasaki R, Watanabe M, Kawasugi K, Takahashi Y, Shirafuji N. Direct Factor X sequestration by systemic amyloid light-chain amyloidosis. Clin Case Rep. 2018 03; 6(3):513-515. PMID: 29531730; PMCID: PMC5838284.
    Citations: 2     
  9. Sugimoto-Sekiguchi H, Tashiro H, Shirasaki R, Arai T, Yamamoto T, Oka Y, Akiyama N, Kawasugi K, Shirafuji N. Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia. Case Rep Gastrointest Med. 2012; 2012:395801. PMID: 23050175.
    Citations: 5     
  10. Shirasaki R, Tashiro H, Oka Y, Matsuo T, Yamamoto T, Sugao T, Akiyama N, Kawasugi K, Shirafuji N. Chronic Myelogenous Leukemia Cells Contribute to the Stromal Myofibroblasts in Leukemic NOD/SCID Mouse In Vivo. J Oncol. 2012; 2012:901783. PMID: 22848221.
    Citations: 1     
  11. Kikuchi H, Yamamoto T, Asako K, Takayama M, Shirasaki R, Ono Y. Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus. Mod Rheumatol. 2012 Apr; 22(2):308-11. PMID: 21773824.
    Citations: 5     Fields:    Translation:Humans
  12. Shirasaki R, Tashiro H, Oka Y, Sugao T, Yamamoto T, Yoshimi M, Akiyama N, Kawasugi K, Shirafuji N. Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19). Int J Hematol. 2011 Aug; 94(2):203-208. PMID: 21732038.
    Citations: 2     Fields:    Translation:HumansCells
  13. Tashiro H, Shirasaki R, Oka Y, Sugao T, Mizutani-Noguchi M, Yamamoto T, Akiyama N, Kawasugi K, Shirafuji N. FLT3 internal tandem duplication is associated with a high relapse rate and central nervous system involvement in acute promyelocytic leukemia cases: single institutional analysis. Eur J Haematol. 2011 Mar; 86(3):272-3. PMID: 21129033.
    Citations: 3     Fields:    Translation:HumansCells
  14. Tashiro H, Umezawa K, Shirota M, Oka Y, Shirasaki R, Nishi R, Taguchi A, Akiyama N, Kawasugi K, Ayabe T, Shirafuji N. [Acute myelogenous leukemia developed at the 26th week of gestation]. Rinsho Ketsueki. 2011 Jan; 52(1):18-22. PMID: 21378477.
    Citations: 1     Fields:    Translation:Humans
  15. Shirasaki R, Tashiro H, Mizutani-Noguchi M, Kawasugi K, Shirafuji N. Chronic myelogenous leukemia cells convert to myofibroblasts in vitro: effect of vascular endothelial growth factor on development of the microenvironment. Leuk Res. 2011 May; 35(5):663-9. PMID: 20952060.
    Citations: 1     Fields:    Translation:HumansCells
  16. Yamamoto T, Tashiro H, Sugao T, Oka Y, Shirasaki R, Kojima K, Akiyama N, Kawasugi K, Shirafuji N, Teramoto T. [Hypercalcemia due to the administration of all-trans retinoic acid for acute promyelocytic leukemia: report of two cases]. Nihon Naika Gakkai Zasshi. 2010 Apr 10; 99(4):828-30. PMID: 20491286.
    Citations:    Fields:    Translation:Humans
  17. Oka Y, Tashiro H, Shirasaki R, Sugao T, Nishi R, Akiyama N, Kawasugi K, Fujimori S, Shirafuji N. Vascular endothelial growth factor acted as autocrine growth factor in an acute promyelocytic leukemia case. Leuk Lymphoma. 2010 Apr; 51(4):717-9. PMID: 20233052.
    Citations: 3     Fields:    Translation:Humans
  18. Oka Y, Tashiro H, Mizutani-Noguchi M, Koga I, Sugao T, Shirasaki R, Miura T, Akiyama N, Kawasugi K, Fujimori S, Shirafuji N. Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART. Int J Hematol. 2010 Jan; 91(1):140-5. PMID: 20033800.
    Citations: 1     Fields:    Translation:HumansCells
  19. Tashiro H, Mizutani-Noguchi M, Shirasaki R, Shirafuji N. Acute myelogenous leukemia cells with the MLL-ELL translocation convert morphologically and functionally into adherent myofibroblasts. Biochem Biophys Res Commun. 2010 Jan 01; 391(1):592-7. PMID: 19932689.
    Citations: 3     Fields:    Translation:HumansCells
  20. Noguchi M, Tashiro H, Shirasaki R, Gotoh M, Kawasugi K, Shirafuji N. Dual-specificity phosphatase 10 is fused to MDS1/EVI1-like gene 1 in a case of acute myelogenous leukemia with der1t1;1(p36.3;q21). Int J Hematol. 2007 Feb; 85(2):175-6. PMID: 17321999.
    Citations:    Fields:    Translation:Humans
  21. Tashiro H, Shirasaki R, Noguchi M, Gotoh M, Kawasugi K, Shirafuji N. Molecular analysis of chronic eosinophilic leukemia with t(4;10) showing good response to imatinib mesylate. Int J Hematol. 2006 Jun; 83(5):433-8. PMID: 16787876.
    Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Shirasaki's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (158)
Co-Authors (13)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.